Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1.

Saved in:
Bibliographic Details
Title: Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1.
Authors: Wilson CS; Department of Pediatrics, Ian Burr Division of Pediatric Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN., Falk A; Department of Pediatrics, Ian Burr Division of Pediatric Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN., Williams JM; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center, Nashville, TN., Hilmes M; Department of Radiology and Radiologic Sciences, Vanderbilt University Medical Center, Nashville, TN., Ross J; Department of Pediatrics, Division of Endocrinology, University of TN Health Sciences Center, TN., LeStourgeon L; Department of Medicine, Vanderbilt University Medical Center, TN., Haller MJ; Department of Pediatrics, Division of Endocrinology, University of Florida, Gainesville, FL., Drawdy M; Department of Pediatrics, Division of Endocrinology, University of Florida, Pensacola, FL., Pechacek J; Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD., Webb T; Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD., Diaz-Thomas A; Department of Pediatrics, Division of Endocrinology, University of TN Health Sciences Center, TN., Russell WE; Department of Pediatrics, Ian Burr Division of Pediatric Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN.; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN., Gregory JM; Department of Pediatrics, Ian Burr Division of Pediatric Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN., Virostko J; Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, Austin, TX., Lionakis MS; Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD., Moore DJ; Department of Pediatrics, Ian Burr Division of Pediatric Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Source: Diabetes care [Diabetes Care] 2026 Jan 01; Vol. 49 (1), pp. 111-117.
Publication Type: Journal Article; Case Reports; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1935-5548
DOI:10.2337/dc25-1444